Gastrooesophageal Cancer
Showing 1 - 8 of 8
Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)
Not yet recruiting
- Gastrooesophageal Cancer
- Trastuzumab deruxtecan
-
Southampton, Hampshire, United Kingdom
- +16 more
Jul 27, 2023
Adenocarcinoma Gastric, Gastrooesophageal Cancer Trial in Worldwide (Ramucirumab (CYRAMZA®), Tusamitamab ravtansine (SAR408701))
Recruiting
- Adenocarcinoma Gastric
- Gastrooesophageal Cancer
- Ramucirumab (CYRAMZA®)
- Tusamitamab ravtansine (SAR408701)
-
Bruxelles, Belgium
- +22 more
Jan 16, 2023
Gastrooesophageal Cancer Trial in Sutton (ibrutinib)
Unknown status
- Gastrooesophageal Cancer
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Trust
Sep 17, 2019
HER-2 Positive Gastric Cancer, Gastrooesophageal Cancer, Esophageal Cancer Trial (Afatinib, Paclitaxel)
Withdrawn
- HER-2 Positive Gastric Cancer
- +2 more
- (no location specified)
Mar 10, 2017
Permission to Collect Blood Over Time for Research
Terminated
- Pancreatic Cancer
- +13 more
- Observation
-
Stanford, CaliforniaStanford University School of Medicine
Jul 6, 2016
Esophageal Cancer, Gastrooesophageal Cancer Trial in Liestal (Esophageal Stump Washout)
Completed
- Esophageal Cancer
- Gastrooesophageal Cancer
- Esophageal Stump Washout
-
Liestal, Basel-Land, SwitzerlandKantonsspital Baselland, Liestal
Feb 24, 2016
B-Receptor Signaling in Cardiomyopathy
Completed
- Carcinomas
- +37 more
-
Stanford, CaliforniaStanford University School of Medicine
Nov 16, 2015